Indevus Pharmaceuticals is a publicly-traded biotechnology company focusing on developing and commercializing speciality pharmaceuticals. Through internal R&D and strategic partnerships, it is advancing the state-of-art of drug delivery with its innovative Hydron Implant technology. Indevus was acquired by Endo Pharmaceuticals (NASDAQ: ENDP).
PO Box 307
Summit, NJ 07902
+1-856-273-6800
We invest in the most promising early-stage, rapid-growth technology companies in the Mid-Atlantic region.
© 2023 Tech Council Ventures, LLC. All Rights Reserved.
Website designed by Lookit® Design , powered by Lookit® QuikSite.
© 2023 Tech Council Ventures, LLC.
All Rights Reserved.
Website designed by Lookit® Design ,
powered by Lookit® QuikSite.
